1. Are nilotinib‐associated vascular adverse events an under‐estimated problem?. (11th March 2015) Authors: Stève‐Dumont, Marie; Baldin, Bernadette; Legros, Laurence; Thyss, Antoine; Re, Daniel; Rocher, Fanny; Ajmia, Florian; Spreux, Anne; Drici, Milou‐Daniel Journal: Fundamental & clinical pharmacology Issue: Volume 29:Number 2(2015) Page Start: 204 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Estimates of population‐based incidence of malignant arrhythmias associated with medication use – a narrative review. (6th July 2020) Authors: Drici, Milou‐Daniel Journal: Fundamental & clinical pharmacology Issue: Volume 34:Number 4(2020) Page Start: 416 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Features of Inflammatory Heart Reactions Following mRNA COVID‐19 Vaccination at a Global Level. Issue 3 (27th December 2021) Authors: Chouchana, Laurent; Blet, Alice; Al‐Khalaf, Mohammad; Kafil, Tahir S.; Nair, Girish; Robblee, James; Drici, Milou‐Daniel; Valnet‐Rabier, Marie‐Blanche; Micallef, Joëlle; Salvo, Francesco; Treluyer, Jean‐Marc; Liu, Peter P. Journal: Clinical pharmacology & therapeutics Issue: Volume 111:Issue 3(2022) Page Start: 605 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Hypertension induced by serotonin reuptake inhibitors: analysis of two pharmacovigilance databases. (11th January 2019) Authors: Humbert, Xavier; Fedrizzi, Sophie; Chrétien, Basile; Sassier, Marion; Bagheri, Haleh; Combret, Sandrine; Drici, Milou‐Daniel; Le Bas, François; Puddu, Paolo E.; Alexandre, Joachim Journal: Fundamental & clinical pharmacology Issue: Volume 33:Number 3(2019) Page Start: 296 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Real‐World Data on the Risk of Ventricular Arrhythmias with Sulfonamides. Issue 2 (2nd May 2022) Authors: Gérard, Alexandre O.; Merino, Diane; Drici, Milou‐Daniel Journal: Clinical pharmacology & therapeutics Issue: Volume 112:Issue 2(2022) Page Start: 201 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Remdesivir and Acute Renal Failure: A Potential Safety Signal From Disproportionality Analysis of the WHO Safety Database. Issue 4 (16th January 2021) Authors: Gérard, Alexandre O.; Laurain, Audrey; Fresse, Audrey; Parassol, Nadège; Muzzone, Marine; Rocher, Fanny; Esnault, Vincent L.M.; Drici, Milou‐Daniel Journal: Clinical pharmacology & therapeutics Issue: Volume 109:Issue 4(2021) Page Start: 1021 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Spontaneous adverse event notifications by patients subsequent to the marketing of a new formulation of Levothyrox® amidst a drug media crisis: atypical profile as compared with other drugs. (7th February 2019) Authors: Viard, Delphine; Parassol‐Girard, Nadège; Romani, Serena; Van Obberghen, Elise; Rocher, Fanny; Berriri, Sofia; Drici, Milou‐Daniel Journal: Fundamental & clinical pharmacology Issue: Volume 33:Number 4(2019) Page Start: 463 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Spontaneous reporting of adverse drug reactions as an outlet for patient dismay? The case of Levothyrox® change of excipients. (18th January 2022) Authors: Romani, Serena; Fresse, Audrey; Parassol‐Girard, Nadège; Gerard, Alexandre; Levraut, Mathieu; Yamani, Samir; Van Obberghen, Elise K.; Pariente, Antoine; Rocher, Fanny; Viard, Delphine; Drici, Milou‐Daniel Journal: Fundamental & clinical pharmacology Issue: Volume 36:Number 3(2022) Page Start: 553 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗